Nothing Special   »   [go: up one dir, main page]

Liu et al., 2010 - Google Patents

A left handed solution to peptide inhibition of the p53-MDM2 interaction

Liu et al., 2010

View HTML
Document ID
5291581058091367505
Author
Liu M
Pazgier M
Li C
Yuan W
Li C
Lu W
Publication year
Publication venue
Angewandte Chemie (International ed. in English)

External Links

Snippet

A left handed solution to peptide inhibition of the p53-MDM2 interaction - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview improvements coming to the PMC website in …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/003General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by transforming the C-terminal amino acid to amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof

Similar Documents

Publication Publication Date Title
Liu et al. A left handed solution to peptide inhibition of the p53-MDM2 interaction
US11912794B2 (en) Modulation of structured polypeptide specificity
Li et al. Apamin as a novel template for structure-based rational design of potent peptide activators of p53
Lu et al. Structure-based peptide inhibitor design of amyloid-β aggregation
Clark et al. Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design
Li et al. Systematic mutational analysis of peptide inhibition of the p53–MDM2/MDMX interactions
Li et al. Limitations of peptide retro-inverso isomerization in molecular mimicry
KR20180128022A (en) A companion diagnostic tool for peptidomimetic giant rings
Schon et al. Binding of p53-derived ligands to MDM2 induces a variety of long range conformational changes
Jadhav et al. Protein secondary structure mimetics: crystal conformations of α/γ 4-hybrid peptide12-helices with proteinogenic side chains and their analogy with α-and β-peptide helices
Wang et al. Protein/peptide secondary structural mimics: design, characterization, and modulation of protein–protein interactions
EP2697249B1 (en) Compounds binding to the bacterial beta ring
Politou et al. The SH3 domain of nebulin binds selectively to type II peptides: theoretical prediction and experimental validation
WO2001085930A2 (en) Methods and compounds for modulating melanocortin receptor ligand binding and activity
Tzeng et al. Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl
Brown et al. Solution structure of a PAN module from the apicomplexan parasite Eimeria tenella
Sonti et al. Conformational Analysis of a 20‐Membered Cyclic Peptide Disulfide from Conus virgo with a WPW Segment: Evidence for an Aromatic–Proline Sandwich
JP2001513823A (en) Rational design of papillomavirus infection-based compounds based on their structure
Pantelejevs et al. A recombinant approach for stapled peptide discovery yields inhibitors of the RAD51 recombinase
Kiss et al. Structure of a hydrophobic leucinostatin derivative determined by host lattice display
Guardiola et al. Target-Templated de novo Design of Macrocyclic D-/L-Peptides: Inhibitors of the PD-1/PD-L1 Interaction
WO2022109053A9 (en) Tyrosyl-lock peptides
Willis Exploring Effects of Aza-Amino Acid Installation on the Secondary Structure of Peptides
Lindemann et al. Structure of the LAV6 peptide: A nucleation site for the correct receptor‐induced refolding of the CD4‐binding domain of HIV1 gp 120
Hana et al. IMPLICATIONS FOR AAA+ ATPASE PROCESSING OF PROTEIN SUBSTRATE LOOPS FROM THE STRUCTURE OF VPS4 BOUND TO A CIRCULAR PEPTIDE